Construction of Metastasis Prediction Models and Screening of Anti-Metastatic Drugs Based on Pan-Cancer Single-Cell EMT Features
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262311582 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yingqi Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heilongjiang Provincial Natural Science Foundation, National Science and Technology Major Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Tumor metastasis is the leading cause of death in cancer patients, with epithelial–mesenchymal transition (EMT) playing a key role. To systematically elucidate the cellular mechanisms and molecular networks through which EMT drives metastasis across cancers, this study integrated transcriptomic data from over 1.2 million single cells across 265 samples representing 12 primary epithelial cancers, constructing a comprehensive pan-cancer single-cell atlas covering diverse stages and metastatic states. By analyzing the metastatic features and interaction networks of malignant epithelial cells and cancer-associated fibroblasts (CAFs), we identified cancer-specific metastasis-related gene sets. Based on these genes, multiple machine learning algorithms were applied to build cancer-specific and cross-cancer metastasis prediction models, leading to the development of the metastasis prediction score (MPS) and global metastasis prediction score (GMPS). Both scores showed excellent predictive performance in independent test and external validation cohorts. MPS exhibited higher cancer specificity, whereas GMPS showed stronger cross-cancer generalization. Moreover, elevated MPS and GMPS reflected immunosuppressive tumor microenvironment features and were significantly associated with poor prognosis across multiple cancer types. Finally, through a drug repositioning framework, we identified several potential anti-metastatic compounds targeting the metastasis network, among which Fostamatinib demonstrated broad-spectrum therapeutic potential against metastasis in multiple cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.
Förderung
- Heilongjiang Provincial Natural Science Foundation
- National Science and Technology Major Program
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Heilongjiang Postdoctoral Fund
- the Key Research and Development Program of Heilongjiang Province
Zitieren
APA
Xu, Y., Luo, Y., Li, M., Lv, N., Deng, Y., Li, N., Wan, S., Gao, X., Li, X., & Hu, C. (2025). Construction of Metastasis Prediction Models and Screening of Anti-Metastatic Drugs Based on Pan-Cancer Single-Cell EMT Features. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311582
Vancouver
Xu Y, Luo Y, Li M, Lv N, Deng Y, Li N, et al. Construction of Metastasis Prediction Models and Screening of Anti-Metastatic Drugs Based on Pan-Cancer Single-Cell EMT Features. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311582
BibTeX
@article{Xu2025,
author = {Xu, Yingqi and Luo, Yawen and Li, Maohao and Lv, Na and Deng, Yuanyuan and Li, Ning and Wan, Shichao and Gao, Xing and Li, Xia and Hu, Congxue},
title = {Construction of Metastasis Prediction Models and Screening of Anti-Metastatic Drugs Based on Pan-Cancer Single-Cell EMT Features},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262311582}
}
EUVIMED